RankingsPricing
  1. JP-listed companies
  2. ROHTO PHARMACEUTICAL CO.,LTD.
  3. Financials
  4. Net income

ROHTO PHARMACEUTICAL CO.,LTD.【JP:4527】

Market cap
¥608.6B
P/E ratio
18.2x
SummaryFinancialsDividendsHistorySegmentsOwnershipWorkforce
Period EndNet income (Million JPY)YoY (%)
Mar 31, 202531,006-1.24%
Mar 31, 202431,394+18.79%
Mar 31, 202326,429+24.96%
Mar 31, 202221,150+26.12%
Mar 31, 202116,770+8.83%
Mar 31, 202015,410+56.96%
Mar 31, 20199,818+5.16%
Mar 31, 20189,336-6.76%
Mar 31, 201710,013+10.06%
Mar 31, 20169,098+5.41%
Mar 31, 20158,631+103.95%
Mar 31, 20144,232-29.27%
Mar 31, 20135,983+7.01%
Mar 31, 20125,591

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)